Figure 3. Prevalence of obesity within each inhaled corticosteroid (ICS) dose group.
Obesity prevalence increased linearly with higher ICS dose group (Cochrane-Armitage test for linear trend Z-statistic=-4.42, p<0.0001).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.